🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Femoral VA ECMO & impella 5.0 walking around our unit whilst awaiting heart Tx. "No one can whistle a symphony, it takes an orchestra to play it" Featuring the team that it takes to make this possible! Consultant, 2x PT, pefusionist & ITU nurse - all highly skilled specialists

#VExUS #POCUS image of the day: Color Doppler of the Femoral vein demonstrating alternating red-blue pattern in a case of #heartfailure and severe venous congestion. (Philippe Rola 's police siren sign) #MedEd #Nephpearls

👻👻 #myxoma

🎯 We’ve completed the #MERCYtrial! 🔀 In 29 Hospitals worldwide we’ve randomized 600 patients with sepsis or septic shock to receive standard bolus vs continuous infusion of #Meropenem 🔗 Learn more pubmed.ncbi.nlm.nih.gov/33684595/   #FOAMcc

2) Simple face mask: 5-10 L/min with FiO2 40-60% 3) Face tent: 10-15 L/min with FiO2 40% 4) Venturi mask 2-15 L/min with FiO2 24-60% 5) Non-rebreather mask: 10-15 L/min with FiO2 80-95% 6) High flow NC: up to 60 L/min with FiO2 21-100%

Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial academic.oup.com/eurheartj/adva… European Society of Cardiology #EHJ #ESCYoung #cardiotwitter EHJ Editor-in-Chief R Ladeiras Lopes

#CritCare #OpenAccess #Propofol may reduce survival in perioperative and critically ill patients. Read the full article: rdcu.be/c9UU8 Jean-Louis Vincent ISICEM #FOAMed #FOAMcc

STEMI in paced rhythm or LBBB: Sgarbossa Criteria 1. Concordant ST elevation ≥ 1mm in a lead with a positive QRS (5pts) 2. ST depression ≥ 1 mm in V1, V2 or V3 (3pts) 3. Discordant ST elevation ≥ 5 mm in a lead with a negative QRS (2pts) ≥3points = 98% specific for ACS

This will be the topic of my thesis discussion! So thrilled!

The use of durable mechanical circulatory support, such as a durable #LVAD, is an important but often underutilized treatment for patients w/ advanced #heartfailure, according to a JACC Scientific Statement. Read more in #JACC: bit.ly/458sGLL JACC Journals

In patients with ST-segment elevation myocardial infarction and multivessel coronary disease, but the optimal timing for revascularization of nonculprit lesions is unknown. Full MULTISTARS AMI trial Research Summary by Barbara Stähli et al.: nej.md/3qLLy54

The SCAI shock classification effectively risk-stratifies cardiac surgery #ICU patients for hospital mortality, postoperative complications & organ dysfunction, thus proving its clinical usefulness in the field of #cvSurg. bit.ly/3M84fY6 #JACC #CardioTwitter

🧵/ Late breaking science results from #AHA23 will be posted to this thread at the time of presentation: SELECT MINT ORBITA-2 CRHCP Dementia POP-HT KARDIA-1 CARDIA-SSBP ARTESIA VERVE-101 ESPRIT SPEC-AI Nigeria SPEECH ⬇️ (bookmark this post)

ORBITA-2, the revenge. In a randomized, placebo-controlled trial of 301 patients with stable angina who stopped all antianginal medications and had evidence of ischemia, the mean angina symptoms score at 12 weeks was lower with PCI than placebo. nejm.org/doi/full/10.10…

Presenting my thesis project on cardiogenic shock complicated by distributive-inflammatory shock at SIC Società Italiana di Cardiologia #SIC84

After approval first in the EU, Finally a TTVI available in the US for our severe, symptomatic TR patients!! European Society of Cardiology American College of Cardiology Susheel Kodali, MD Vinod Thourani

This beautiful review led by Iris Beldhuis Kevin Damman in Circulation describes 📌the paradox of greater risk but under treatment when #HF is accompanied by #CKD 📌the #evidence base to guide #GDMT use across #EGFR ahajournals.org/doi/pdf/10.116…

Just presented our new #ESOVENTTrial at ITACTAIC ! Proud and thrilled to share our project on improving clinical outcomes in patients undergoing esophagectomy!

Just released our review on cardiac imaging for guiding AF ablation